Written answers

Thursday, 29 April 2010

Department of Health and Children

Medicinal Products

Photo of Willie PenroseWillie Penrose (Longford-Westmeath, Labour)
Link to this: Individually | In context

Question 135: To ask the Minister for Health and Children if she is proposing to introduce a scheme called reference pricing and generic substitution for all prescription drugs here; if same will include osteoporosis drugs; the discussion she has had with osteoporosis specialists and their patients in relation to the effectiveness of such policy; if her attention has been drawn to the fact that it may be a false economy in particular in relation to osteoporosis medications; and if she will make a statement on the matter. [17474/10]

Photo of Mary HarneyMary Harney (Dublin Mid West, Independent)
Link to this: Individually | In context

The Government has decided to introduce a system of reference pricing combined with generic substitution under the GMS and community drugs schemes. This will promote price competition and deliver ongoing savings for both the State and for patients. A working group, made up of officials and healthcare professionals from my Department and the HSE, is setting out proposed steps for implementing this initiative. I expect to see significant progress on this in 2010, including the identification of legislative and administrative changes required to give it effect in 2011. There are some categories of medicines that are not suitable for substitution. In addition, there are also certain circumstances where an individual patient should receive a particular product.

With a system of generic substitution, it is important that all decisions about the interchangeability of medicines are evidence-based and take into account best practice elsewhere. It is envisaged that an expert group will provide guidance on this matter. I have received correspondence from the Irish Osteoporosis Society in relation to studies on the usage of generic versions of a particular medicine used for the treatment of osteoporosis. This information will be taken into account during the implementation process.

Comments

No comments

Log in or join to post a public comment.